论文部分内容阅读
我院自1982年8月～1987年4月共埋植了经静脉永久性心脏起搏器35例(包括外院安置后出现并发症来我院治疗的2例)。男28例,女7例,年龄28～79岁,平均52.7岁其中Ⅲ度房室传导阻滞30例(三束支阻滞7例),病态窦房结综合症5例(快慢型2例)。35例中,冠心病16例,合并高血压6例,合并糖尿病4例,合并颈椎病5例;心肌炎或心肌病者3例;原发性传导束退化症1例。11例患者先行临时起搏1～61天,平均11.9天后改为永久性起搏,其余24例直接永久性起搏。起搏器均为ⅤⅥ型,进口起搏器27只(厂家有CPI、Edward、Metro-nics、CPM、Telectronic等公司),国产8只。
Our hospital from August 1982 to April 1987 were implanted in a total of 35 cases of intravenous permanent pacemaker (including complications of hospital placement after treatment to our hospital in 2 cases). 28 males and 7 females, aged 28 to 79 years, mean 52.7 years of which Ⅲ degree atrioventricular block in 30 cases (triple bundle branch block in 7 cases), sick sinus syndrome in 5 cases (fast type 2 cases ). Among the 35 cases, 16 were coronary heart disease, 6 with hypertension, 4 with diabetes, 5 with cervical spondylosis, 3 with myocarditis or cardiomyopathy, and 1 with degenerative primary bundle degeneration. Eleven patients underwent provisional pacing for 1 to 61 days, with an average of 11.9 days after the change to permanent pacing, and the remaining 24 patients undergoing direct pacing. Pacemakers are Ⅴ Ⅵ type, import pacemaker 27 (manufacturers have CPI, Edward, Metro-nics, CPM, Telectronic and other companies), made eight.